Sign in
Taking people in United StatesPhase 2/3

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

Key facts

Who runs it
University of Washington
Where
Birmingham, Houston, Oklahoma City, Seattle, Tacoma, and Tampa, United StatesSee the 6 sites
Trial code
Status
Recruiting
Phase
Phase 2/3
People taking part
350 people, planned
Started
3 Jul 2025
Expected to end
28 Feb 2031
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Limited Trophic Feeds (1 day of trophic feeds)
  • Extended Trophic Feeds (3 days of trophics)
Record updated
17 August 2026

Who can take part

Age
0 years to 2 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • <1500 gram birthweight
  • 25w0d-31w6d at birth
  • Consent to feed donor milk when parent's own milk is not available or of insufficient quantity

Who cannot take part

  • Congenital anomaly affecting decisions on enteral feedings (e.g. gastroschisis, omphalocele, congenital diaphragmatic hernia, congenital heart disease, etc.)
  • Known genetic condition affecting growth, feeding, or mortality
  • <5th percentile for weight at birth (Fenton growth curve)
  • Parent or legal guardian unable to provide consent within 36 hours after birth
  • Vasopressor use within first 24 hours after birth (not including hydrocortisone)
  • Considered terminally ill

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 2 years old?

Where in United States

  • University of Alabama at BirminghamBirmingham, United StatesContact: Ariel Salas, MD MSPHNot yet recruiting
  • Baylor College of MedicineHouston, United StatesContact: Amy B Hair, MDNot yet recruiting
  • University of OklahomaOklahoma City, United StatesContact: Erynn Bergner, MDNot yet recruiting
  • University of WashingtonSeattle, United StatesContact: Gregory C Valentine, MD MED FAAPNot yet recruiting
  • St. Joseph's Medical CenterTacoma, United StatesContact: Gregory C Valentine, MD MED FAAPTaking people
  • University of South FloridaTampa, United StatesContact: Steven Ford, MDNot yet recruiting

About the trial

What the trial wants to find out

Study Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all-cause late onset sepsis (LOS) without increasing the risk of other adverse outcomes.

Read full original descriptionShow less

Study Design Type This is a multi-center, open-label, parallel-group, individual randomized controlled trial comparing two different trophic feeding regimens in preterm infants born between 25w0d and 31w6d. These infants will be randomly assigned to either the intervention group, receiving limited trophic feeding (20 to 25 mL/kg/day for one day) or the control group, receiving extended trophic feeding (20 to 25 mL/kg/day for three days) prior to advancing enteral feeds until full feeding volume (140 mL/kg/day) is achieved.

Eligibility Criteria Preterm infants with gestational ages between 25 0/7 and 31 6/7 weeks and a birthweight of <1500 grams who are admitted to six participating neonatal units will be eligible for inclusion. Infants with <5th percentile for weight at birth, vasopressor use within first 24 hours of life major congenital/genetic anomalies affecting enteral feeding, growth, or mortality, and those with a terminal illness in which decisions to withhold or limit support have been made will be excluded. Infants of parents or legal guardians who are unable to provide consent within 36 hours of birth will also be excluded.

Study Intervention/Methods Written parental informed consent will be obtained prenatally or within the first 36 hours of birth. Infants will be randomized to receive limited trophic feeds of 24 to 36 hours or extended trophic feeds for 72 hours prior to the advancement of enteral feeds. Infants will be fed parent's own milk (POM) with donor human milk as the alternative if POM is unavailable.

Primary Outcome Late-onset sepsis, defined as positive blood, urine, and/or cerebrospinal fluid (CSF) cultures in the presence of compatible clinical signs of sepsis, occurring after postnatal day 3 and before hospital discharge, and treated with antibiotics for 5 days or more.

Secondary Outcome(s) The trial will assess various secondary outcomes including length of hospital stay, all-cause in-hospital mortality, duration of IV fluids and central line utilization, necrotizing enterocolitis (Bell's stage IIa or higher), severe intraventricular hemorrhage (grade III or IV either unilaterally or bilaterally), bronchopulmonary dysplasia (oxygen requirement or positive pressure ventilation at 36 weeks corrected gestational age), or retinopathy of prematurity requiring intervention. Additionally, growth metrics throughout hospitalization will be evaluated using change in weight, length, and head circumference z-scores from birth to 36 weeks' corrected gestational age between infants in the limited and extended trophic feeding groups.

We will also evaluate the 2 year developmental outcomes of a subset of participants who consent to follow up. This will include the Bayley Scales of Infant and Toddler Development-4th edition Language, Cognitive, and Motor domain scores at 2 years corrected age.

The 2 groups in the trial

  • Extended Trophic FeedingExisting treatment, for comparison

    Advancing enteral feeds after 3 days of trophic feeds of 20-25 mL/kg birthweight/day. Advancement of enteral feeds will be by approximately 30 mL/kg birthweight/day after 3 days of trophic feeds. Advancement will occur until achieving at least 140 mL/kg birthweight/day of enteral feeds. Enteral feeds will consist of parent's own milk or donor human milk.

    Treatment: Extended Trophic Feeds (3 days of trophics)

  • Limited Trophic FeedsTreatment being tested

    Advancing enteral feeds after 1 day of trophic feeds of 20-25 mL/kg birthweight/day. Advancement of enteral feeds will be by approximately 30 mL/kg birthweight/day until achieving at least 140 mL/kg birthweight/day of enteral feeds. Enteral feeds will consist of parent's own milk or donor human milk.

    Treatment: Limited Trophic Feeds (1 day of trophic feeds)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06893939, who can take part
Record updated
17 August 2026